Trials / Completed
CompletedNCT01139567
Tissue Perfusion and Blood Flow Monitoring Technology
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (estimated)
- Sponsor
- CW Optics, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and efficacy of an optical device designed and developed to quantitatively monitor blood flow velocity of wound sites. The hypothesis is that the blood flow velocity of the wound site will provide critical information on the efficacy of hyperbaric oxygen therapy.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2010-06-08
- Last updated
- 2013-07-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01139567. Inclusion in this directory is not an endorsement.